GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs
Nessun attività
Obbligazioni
Di seguito è riportato l'elenco delle obbligazioni societarie GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs. Gli investitori spesso optano per le obbligazioni di una società per la loro maggiore stabilità in tempi di volatilità del mercato. Studia i prezzi, i rendimenti e altre statistiche per trovare un investimento affidabile.
Simbolo | YTM % | Volume | Prezzo % | Cedola % | Data di maturazione | Importo in eccesso | Valore nominale | Importo min. denominazione | Emittente |
|---|---|---|---|---|---|---|---|---|---|
| 117RIGlaxoSmithKline Capital Plc 4.25% 18-DEC-2045 | 5,61% | 8,46 K | 82,51% | 4,250% | 2045-12-18 | 370,79 M GBP | 1.000,00 GBP | 100.000,00 GBP | GlaxoSmithKline Capital Plc |
| 883GIGlaxoSmithKline Capital Plc 5.25% 10-APR-2042 | 5,54% | 0 | 96,88% | 5,250% | 2042-04-10 | 477,82 M GBP | 1.000,00 GBP | 50.000,00 GBP | GlaxoSmithKline Capital Plc |
| 771ZCGlaxoSmithKline Capital Plc 6.375% 09-MAR-2039 | 5,45% | 0 | 108,50% | 6,375% | 2039-03-09 | 631,3 M GBP | 1.000,00 GBP | 50.000,00 GBP | GlaxoSmithKline Capital Plc |
| GGSK3981911GlaxoSmithKline Capital, Inc. 4.2% 18-MAR-2043 | 5,31% | 4,29 M | 87,55% | 4,200% | 2043-03-18 | 500 M USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital, Inc. |
| XXS217060907GlaxoSmithKline Capital Plc 1.625% 12-MAY-2035 | 5,09% | 0 | 74,53% | 1,625% | 2035-05-12 | 750 M GBP | 1.000,00 GBP | 100.000,00 GBP | GlaxoSmithKline Capital Plc |
| GGSK.GJGlaxoSmithKline Capital, Inc. 6.375% 15-MAY-2038 | 4,99% | 210 K | 112,70% | 6,375% | 2038-05-15 | 2,75 B USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital, Inc. |
| GGSK6023693GlaxoSmithKline Capital, Inc. 4.875% 15-APR-2035 | 4,71% | 50 K | 101,19% | 4,875% | 2035-04-15 | 750 M USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital, Inc. |
| 772WIGlaxoSmithKline Capital, Inc. 5.375% 15-APR-2034 | 4,67% | 0 | 105,28% | 5,375% | 2034-04-15 | 500 M USD | 1.000,00 USD | 1.000,00 USD | GlaxoSmithKline Capital, Inc. |
| AAG99GlaxoSmithKline Capital Plc 5.25% 19-DEC-2033 | 4,58% | 0 | 104,45% | 5,250% | 2033-12-19 | 574,17 M GBP | 1.000,00 GBP | 1.000,00 GBP | GlaxoSmithKline Capital Plc |
| GGSK6023695GlaxoSmithKline Capital, Inc. 4.5% 15-APR-2030 | 4,16% | 415 K | 101,32% | 4,500% | 2030-04-15 | 850 M USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital, Inc. |
| UUS377373AH8GlaxoSmithKline Capital Plc 3.375% 01-JUN-2029 | 4,13% | 0 | 97,56% | 3,375% | 2029-06-01 | 1 B USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital Plc |
| UUS377372AN7GlaxoSmithKline Capital, Inc. 3.875% 15-MAY-2028 | 4,08% | 0 | 99,56% | 3,875% | 2028-05-15 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital, Inc. |
| XXS217060184GlaxoSmithKline Capital Plc 1.25% 12-OCT-2028 | 4,06% | 0 | 92,61% | 1,250% | 2028-10-12 | 750 M GBP | 1.000,00 GBP | 100.000,00 GBP | GlaxoSmithKline Capital Plc |
| GGSK6023691GlaxoSmithKline Capital Plc 4.315% 12-MAR-2027 | 3,78% | 550 K | 100,66% | 4,315% | 2027-03-12 | 400 M USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital Plc |
| XXS293369275GSK Capital BV 3.25% 19-NOV-2036 | 3,69% | 0 | 96,06% | 3,250% | 2036-11-19 | 600 M EUR | 1.000,00 EUR | 100.000,00 EUR | GSK Capital BV |
| XXS255381776GSK Capital BV 3.125% 28-NOV-2032 | 3,38% | 0 | 98,43% | 3,125% | 2032-11-28 | 700 M EUR | 1.000,00 EUR | 100.000,00 EUR | GSK Capital BV |
| XXS293369143GSK Capital BV 2.875% 19-NOV-2031 | 3,14% | 0 | 98,59% | 2,875% | 2031-11-19 | 700 M EUR | 1.000,00 EUR | 100.000,00 EUR | GSK Capital BV |
| XXS182282979GlaxoSmithKline Capital Plc 1.75% 21-MAY-2030 | 2,90% | 0 | 95,26% | 1,750% | 2030-05-21 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | GlaxoSmithKline Capital Plc |
| XXS168152035GlaxoSmithKline Capital Plc 1.375% 12-SEP-2029 | 2,84% | 0 | 94,83% | 1,375% | 2029-09-12 | 500 M EUR | 1.000,00 EUR | 100.000,00 EUR | GlaxoSmithKline Capital Plc |
| XXS255381768GSK Capital BV 3.0% 28-NOV-2027 | 2,56% | 0 | 100,83% | 3,000% | 2027-11-28 | 500 M EUR | 1.000,00 EUR | 100.000,00 EUR | GSK Capital BV |
| GGX5BGlaxoSmithKline Capital Plc 1.0% 12-SEP-2026 | 2,30% | 0 | 99,04% | 1,000% | 2026-09-12 | 700 M EUR | 1.000,00 EUR | 100.000,00 EUR | GlaxoSmithKline Capital Plc |
| XXS182282812GlaxoSmithKline Capital Plc 1.25% 21-MAY-2026 | 2,29% | 0 | 99,54% | 1,250% | 2026-05-21 | 1 B EUR | 1.000,00 EUR | 100.000,00 EUR | GlaxoSmithKline Capital Plc |
| 117RNGlaxoSmithKline Capital Plc 3.375% 20-DEC-2027 | 0,87% | 0 | 112,19% | 3,375% | 2027-12-20 | 307,77 M GBP | 1.000,00 GBP | 100.000,00 GBP | GlaxoSmithKline Capital Plc |
| GGSK6023692GlaxoSmithKline Capital Plc FRN 12-MAR-2027 | — | 3,94 M | 100,33% | 4,651% | 2027-03-12 | 600 M USD | 1.000,00 USD | 2.000,00 USD | GlaxoSmithKline Capital Plc |
| AAQ72GlaxoSmithKline Capital Plc 0.883% 21-SEP-2028 | — | — | — | 0,883% | 2028-09-21 | 42,5 B JPY | 100.000.000,00 JPY | 100.000.000,00 JPY | GlaxoSmithKline Capital Plc |